M.D. Sass Investors Services, Inc. Vertex Pharmaceuticals Inc Transaction History

M.D. Sass Investors Services, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $16.2 Million - $20.2 Million	-69,101 Reduced 47.28%	77,059 $21.7 Million
Q1 2022 May 12, 2022	BUY	$221.42 - $260.97 $12 Million - $14.2 Million	54,275 Added 59.07%	146,160 $38.1 Million
Q4 2021 Feb 03, 2022	BUY	$177.01 - $223.45 $16.3 Million - $20.5 Million	91,885 New	91,885 $20.2 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of M.D. Sass Investors Services, Inc., based on Form 13F filings with the SEC.

Stay updated on M.D. Sass Investors Services, Inc. with notifications on news.